A detailed history of Guinness Asset Management LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Guinness Asset Management LTD holds 1,159,779 shares of ABBV stock, worth $209 Million. This represents 4.35% of its overall portfolio holdings.

Number of Shares
1,159,779
Previous 1,109,044 4.57%
Holding current value
$209 Million
Previous $190 Million 20.4%
% of portfolio
4.35%
Previous 3.92%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$163.84 - $199.33 $8.31 Million - $10.1 Million
50,735 Added 4.57%
1,159,779 $229 Million
Q2 2024

Jul 11, 2024

SELL
$154.79 - $180.76 $20.8 Million - $24.3 Million
-134,532 Reduced 10.82%
1,109,044 $190 Million
Q1 2024

Apr 11, 2024

SELL
$159.82 - $182.1 $2.76 Million - $3.15 Million
-17,274 Reduced 1.37%
1,243,576 $226 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $125,216 - $141,022
910 Added 0.07%
1,260,850 $195 Million
Q3 2023

Nov 06, 2023

BUY
$133.59 - $154.65 $43.8 Million - $50.7 Million
327,755 Added 35.16%
1,259,940 $188 Million
Q2 2023

Jul 24, 2023

BUY
$132.51 - $164.9 $10 Million - $12.5 Million
75,525 Added 8.82%
932,185 $126 Million
Q1 2023

Apr 10, 2023

BUY
$144.61 - $166.54 $12.2 Million - $14 Million
84,137 Added 10.89%
856,660 $137 Million
Q4 2022

Feb 02, 2023

SELL
$138.31 - $165.87 $31.2 Million - $37.4 Million
-225,323 Reduced 22.58%
772,523 $125 Million
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $28.2 Million - $32.3 Million
209,932 Added 26.64%
997,846 $134 Million
Q2 2022

Sep 06, 2022

BUY
$137.62 - $174.96 $10 Million - $12.7 Million
72,809 Added 10.18%
787,914 $121 Million
Q1 2022

Apr 13, 2022

BUY
$131.98 - $163.75 $3.54 Million - $4.4 Million
26,841 Added 3.9%
715,105 $116 Million
Q4 2021

Jan 19, 2022

BUY
$107.43 - $135.93 $11.1 Million - $14.1 Million
103,447 Added 17.69%
688,264 $93.2 Million
Q3 2021

Dec 07, 2021

BUY
$106.4 - $120.78 $10.4 Million - $11.8 Million
97,357 Added 19.97%
584,817 $73.1 Million
Q2 2021

Aug 03, 2021

BUY
$105.21 - $117.21 $133,616 - $148,856
1,270 Added 0.26%
487,460 $54.9 Million
Q1 2021

Apr 21, 2021

SELL
$102.3 - $112.62 $603,570 - $664,458
-5,900 Reduced 1.2%
486,190 $52.6 Million
Q4 2020

Jan 25, 2021

BUY
$80.49 - $108.67 $9.06 Million - $12.2 Million
112,540 Added 29.65%
492,090 $52.7 Million
Q3 2020

Oct 27, 2020

BUY
$85.91 - $100.83 $348,794 - $409,369
4,060 Added 1.08%
379,550 $33.2 Million
Q2 2020

Jul 28, 2020

SELL
$73.37 - $98.18 $4.14 Million - $5.54 Million
-56,400 Reduced 13.06%
375,490 $36.9 Million
Q1 2020

Apr 30, 2020

BUY
$64.5 - $97.79 $483,750 - $733,425
7,500 Added 1.77%
431,890 $32.9 Million
Q4 2019

Feb 04, 2020

BUY
$72.13 - $90.25 $1.46 Million - $1.83 Million
20,300 Added 5.02%
424,390 $37.6 Million
Q3 2019

Oct 28, 2019

BUY
$62.98 - $75.72 $7.06 Million - $8.48 Million
112,040 Added 38.36%
404,090 $30.6 Million
Q2 2019

Jul 26, 2019

BUY
$65.7 - $83.98 $4.72 Million - $6.03 Million
71,840 Added 32.62%
292,050 $21.2 Million
Q4 2018

Jan 28, 2019

BUY
$77.85 - $96.01 $4.27 Million - $5.27 Million
54,840 Added 33.16%
220,210 $20.3 Million
Q3 2018

Oct 17, 2018

BUY
$88.91 - $98.84 $1.75 Million - $1.95 Million
19,710 Added 13.53%
165,370 $15.6 Million
Q2 2018

Aug 16, 2018

BUY
$89.78 - $106.23 $2.69 Million - $3.18 Million
29,910 Added 25.84%
145,660 $13.5 Million
Q1 2018

Apr 17, 2018

SELL
$92.01 - $123.21 $1.78 Million - $2.38 Million
-19,350 Reduced 14.32%
115,750 $11 Million
Q4 2017

Jan 29, 2018

BUY
$89.56 - $98.21 $12.1 Million - $13.3 Million
135,100
135,100 $13.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Guinness Asset Management LTD Portfolio

Follow Guinness Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guinness Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Guinness Asset Management LTD with notifications on news.